Fluocortolone
From Wikipedia, the free encyclopedia
|
Fluocortolone
|
|
| Systematic (IUPAC) name | |
| (6S,8S,9R,10S,11S,13S,14S,16R,17S)- 6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)- 10,13,16-trimethyl-6,7,8,9,11,12,14,15,16,17- decahydrocyclopenta[a]phenanthren-3-one |
|
| Identifiers | |
| CAS number | |
| ATC code | C05 D07AC05 H02AB03 |
| PubChem | |
| Chemical data | |
| Formula | C22H29FO4 |
| Mol. mass | 376.462 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Fluocortolone is a glucocorticoid used in the treatment of several conditions, including hemorrhoids.
|
|||||||||||
|
|||||||||||

